<i>In Vitro</i> Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae.

Farrell, D J; Sader, H S; Rhomberg, P R; Scangarella-Oman, N E; Flamm, R K.
Antimicrob Agents Chemother; 61(3)2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28069643

Documentos relacionados

  1. Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.
  2. Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.
  3. Fluoroquinolone resistance and mutation patterns in gyrA and parC genes in Neisseria gonorrhoeae isolates from Shanghai, China.
  4. Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.
  5. Exploring quinolone resistance-determining region in <i>Neisseria gonorrhoeae</i> isolates from across India.
  6. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
  7. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.
  8. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
  9. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
  10. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance.